Incidence of ovarian cancer after hysterectomy: A nationwide controlled follow up

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 11, 1997, Pages 1296-1301

  Loft, Anne ^a   Lidegaard, Øjvind ^b   Tabor, Ann ^c  

^a University of Copenhagen   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; INCIDENCE; MAJOR CLINICAL STUDY; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; REGISTRATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0030706203     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb10978.x     Document Type: Article

References (41)

1. Madsen EM, Lidegaard Ø, Tabor A. Oophorectomy per occasionem and cancer of the ovary. Ugeskr Laeger 1992; 154: 3221–3225.
2. Bertelsen K. Ovarian cancer. Prognostic factors, survival, and resources [PhD thesis]. Odense, Denmark: University of Odense; 1995. Risskov, Denmark: self-published, 1995.
3. Studd J. Prophylactic oophorectomy. Br J Obstet Gynaecol 1989; 96: 506–509.
4. Li TC, Saravelos H. Oophorectomy at the same time as hysterectomy. Br J Obstet Gynaecol 1994; 101: 934–936.
5. Piver MS, Wong C. Prophylactic oophorectomy: a century long dilemma. Hum Reprod 1997; 12: 205–206.
6. Andersen TF, Madsen M, Loft A. Prevalence of hysterectomized women in the Danish population in 1983. Ugeskr Laeger 1987; 149: 615–619.
7. Rosenblatt KA, Thomas DB, The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives: reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. Cancer Epidemiol Biomarkers Prev 1996; 5: 933–935.
8. Purdie D, Green A, Bain C et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Int J Cancer 1995; 62: 678–684.
9. Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994; 140: 585–597.
10. Rosenberg L, Palmer JR, Zauber AG et al. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994; 139: 654–661.
11. Parazzini F, Negri E, La Vecchia C, Luchini L, Mezzopane R. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstet Gynecol 1993; 81: 363–366.
12. Whittemore AS, Harris R, Itnyre J, the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case- control studies: II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 1184–1203.
13. Irwin KL, Weiss NS, Lee NC, Peterson HB. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol 1991; 134: 362–369.
14. Weiss NS, Harlow BL. Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer. Am J Epidemiol 1986; 124: 856–858.
15. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: a case- control study. BrJ Cancer 1989; 60: 592–598.
16. Hankinson SE, Hunter DJ, Colditz GA et al. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA 1993; 270: 2813–2818.
17. The International Classification of Diseases. Eighth revision, Sundhedsstyrelsen 1982.
18. The National Classification of Treatments. Second revision, Sundhedsstyrelsen 1980.
19. Andersen TF, Madsen M, Loft A. Validity of surgical information from the Danish National Patient Register with particular attention to the analysis of regional variations in the hysterectomy rate. Ugeskr Laeger 1987; 149: 2420–2422.
20. Østerlind A, Jensen OM. Evaluation of registration of cancer cases in Denmark 1977. Ugeskr Laeger 1985; 147: 2483–2488.
21. Cramer DW, Welch WR, Scully RE, Wojciechowski CA. Ovarian cancer and talc. A case-control study. Cancer 1982; 50: 372–376.
22. Sightler SE, Boike GM, Estape RE, Averette HE. Ovarian cancer in women with prior hysterectomy: A 14-year experience at the University of Miami. Obstet Gynecol 1991; 78: 681–684.
23. Speroff T, Dawson NV, Speroff L, Haber RJ. A risk-benefit analysis of elective bilateral oophorectomy: effect of changes in compliance with estrogen therapy on outcome. Am J Obstet Gynecol 1991; 164: 165–174.
24. Meijer WJ, van Lindert ACM. Prophylactic oophorectomy. Eur J Obstet Gynecol Reprod Biol 1992; 47: 59–65.
25. Nilas L, Loft A. Ovarian function following premenopausal hysterectomy. Ugeskr Laeger 1993; 155: 3818–3822.
26. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987; 47: 94–100.
27. Christ JE, Lotze EC. The residual ovary syndrome. Obstet Gynecol 1975; 46: 551–556.
28. Riedel H-H, Lehmann-Willenbrock E, Semm K. Ovarian failure phenomena after hysterectomy. J Reprod Med 1986; 31: 597–600.
29. Seeley T. Oestrogen replacement therapy after hysterectomy. BMJ 1992; 305: 811–812.
30. Souza AZ, Fonseca AM, Izzo VM, Clauzet RM, Salvartore CA. Ovarian histology and function after total abdominal hysterectomy. Obstet Gynecol 1986; 68: 847–849.
31. Stone SC, Dickey RP, Mickal A. The acute effect of hysterectomy on ovarian function. Am J Obstet Gynecol 1975; 121: 193–197.
32. Beksac MS, Kisnisci HA, Cakar AN, Beksac M. The endocrinologi-cal evaluation of bilateral and unilateral oophorectomy in premenopausal women. Int J Fertil 1983; 28: 219–224.
33. Menon RK, Okonofua FE, Agnew JE, Thomas M, Bell J, O’Brian PMS, Dandona P. Endocrine and metabolic effects of simple hysterectomy. Int J Gynaecol Obstet 1987; 25: 459–463.
34. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978; 89: 157–161.
35. Centerwall BS. Premenopausal hysterectomy and cardiovascular disease. Am J Obstet Gynecol 1981; 139: 58–61.
36. Punnonen R, Jkäläinen M, Seppälä E. Premenopausal hysterectomy and the risk of cardiovascular disease. Lancet 1987; 1: 1139.
37. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol 1981; 139: 47–51.
38. Watson NR, Studd JWW, Gamett T, Savvas M, Milligan P. Bone loss after hysterectomy with ovarian conservation. Obstet Gynecol 1995; 86: 72–77.
39. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987; 49: 397–409.
40. Mortola JF, Yen SS. The effect of oral dehydroepiandrosterone on endocrine- metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 1990; 71 696–704.
41. Lindhard A, Nilas L. The postmenopausal ovary—should it be preserved Ugeskr Laeger 1994; 156: 7018–7023.